Cancer SRPs nationally
Regional Cancer Center (RCC)
Regional Cancer Center Stockholm - Gotland will lead and coordinate the region's efforts to streamline cancer care processes. StratCan has close collaboration with RCC, strengthened by the fact that Roger Henriksson, co-director of StratCan, is head of RCC Stockholm - Gotland. A significant joint effort is the recruitment of Professor Per Ljungman as Research Coordinator at RCC.
StratCan has established a research environment and meeting point for the most competitive cancer research at KI. StratCan brings together research groups and research centers (the three Translational Thematic Centers - ACT, BRECT, IMTAC - and the two Linné centers within cancer research - CRisP, STARGET) spread over many different departments and three geographical locations.
Translational Thematic Centers
The theme centers are set up jointly by the Karolinska Institutet and Stockholm County Council to promote the transfer of basic research to clinical application. StratCan has close collaboration with the three theme centers in cancer research (ACT, BRECT, IMTAC) and their directors are members of the Executive Board.
- Breast Cancer Theme Center (BRECT)
The breast cancer theme center aims to increase our understanding of critical steps in breast cancer development and therapy. The research span from basic studies using cell lines, animal models and patient biopsies, to prospective clinical studies and clinical trials, with the ultimate goal to improve breast cancer therapy and disease outcome. Director Jonas Bergh.
- Center for Advanced Cancer Therapies (ACT)
The aim of ACT is to identify and characterize novel compounds that target critical pathways in cancer cells. A multidisciplinary approach that integrates clinical research with state of the art HTP screening of chemical libraries and target identification/validation technologies, including cell and molecular biology, transcriptomics, proteomics, computational biology and in vivo imaging techniques is used. Director: Galina Selivanova.
- Theme Center for Immune Modulatory Therapies (IMTAC)
The main focus of IMTAC is developing innovative immune-based treatment approaches and accelerating the movement of effective immunotherapies into the clinic as part of the standard of care for patients. Director: Rolf Kiessling.
The Swedish Research Council provides support to a total of 40 research environments in different research areas through a 5-10-year Linnaeus grant allocated in 2006 and 2008. The aim of the Linnaeus grants is to enhance support for research of the highest quality that can compete internationally. It also aims to encourage universities and colleges to prioritize research fields and to allocate funding for them. StratCan has close collaboration with the Linnaeus Centers in Cancer Research at Karolinska Institutet, and their directors are members of the Executive Board.
- CRisP - The Cancer Risk Prediction Center
The translational research environment CRisP covers the fields of cancer epidemiology, next-generation sequencing, biostatistics, systems biology, pathology, surgery and quality-of-life research. CRisP was established in 2008 based on a shared vision of decreased breast and prostate cancer mortality through individualized risk prediction and prevention. Coordinated by Henrik Grönberg.
- STARGET - a Cancer Research Network
STARGET is a cancer research network at Karolinska Institutet dedicated to a systematic characterization of the roles of pericytes and fibroblasts in normal and tumor tissue. It is the only Linné center dedicated to experimental cancer research. STARGET i supported by the Swedish Research Council since 2006. Coordinated by Arne Östman.